Skip to main content

previous disabled Page of 3
and
  1. Article

    Open Access

    The Infarct-Limiting Effect of Remote Ischemic Conditioning in Rats Is Not Affected by Aspirin

    Remote ischemic conditioning (RIC) has been shown to be a powerful cardioprotective therapy in animal models. However, a protective effect in patients presenting with acute myocardial infarction has failed to ...

    M. V. Basalay, James M. Downey, S. M. Davidson in Cardiovascular Drugs and Therapy (2023)

  2. Article

    Open Access

    Remote ischaemic conditioning: defining critical criteria for success—report from the 11th Hatter Cardiovascular Workshop

    The Hatter Cardiovascular Institute biennial workshop, originally scheduled for April 2020 but postponed for 2 years due to the Covid pandemic, was organised to debate and discuss the future of Remote Ischaemi...

    R. M. Bell, M. Basalay, H. E. Bøtker in Basic Research in Cardiology (2022)

  3. Article

    Open Access

    Correction: Hearts deficient in both Mfn1 and Mfn2 are protected against acute myocardial infarction

    A. R. Hall, N. Burke, R. K. Dongworth, S. B. Kalkhoran, A. Dyson in Cell Death & Disease (2021)

  4. Article

    Open Access

    Targeting myocardial ischaemic injury in the absence of reperfusion

    Sudden myocardial ischaemia causes an acute coronary syndrome. In the case of ST-elevation myocardial infarction (STEMI), this is usually caused by the acute rupture of atherosclerotic plaque and obstruction o...

    M. V. Basalay, D. M. Yellon, S. M. Davidson in Basic Research in Cardiology (2020)

  5. Article

    Open Access

    Intrinsic cardiac ganglia and acetylcholine are important in the mechanism of ischaemic preconditioning

    This study aimed to investigate the role of the intrinsic cardiac nervous system in the mechanism of classical myocardial ischaemic preconditioning (IPC). Isolated perfused rat hearts were subjected to 35-min ...

    J. M. J. Pickard, N. Burke, S. M. Davidson, D. M. Yellon in Basic Research in Cardiology (2017)

  6. Article

    Open Access

    9th Hatter Biannual Meeting: position document on ischaemia/reperfusion injury, conditioning and the ten commandments of cardioprotection

    In the 30 years since the original description of ischaemic preconditioning, understanding of the pathophysiology of ischaemia/reperfusion injury and concepts of cardioprotection have been revolutionised. In t...

    R. M. Bell, H. E. Bøtker, R. D. Carr, S. M. Davidson in Basic Research in Cardiology (2016)

  7. Article

    Open Access

    Hearts deficient in both Mfn1 and Mfn2 are protected against acute myocardial infarction

    Mitochondria alter their shape by undergoing cycles of fusion and fission. Changes in mitochondrial morphology impact on the cellular response to stress, and their interactions with other organelles such as th...

    A R Hall, N Burke, R K Dongworth, S B Kalkhoran, A Dyson in Cell Death & Disease (2016)

  8. Article

    Open Access

    Exogenous SDF-1α Protects Human Myocardium from Hypoxia-Reoxygenation Injury via CXCR4

    A. Malik, D. I. Bromage, Z. He, L. Candilio in Cardiovascular Drugs and Therapy (2015)

  9. Article

    Open Access

    Cardioprotective Properties of the Platelet P2Y12 Receptor Inhibitor, Cangrelor: Protective in Diabetics and Reliant Upon the Presence of Blood

    R. M. Bell, V. Sivaraman, S. P. Kunuthur, M. V. Cohen in Cardiovascular Drugs and Therapy (2015)

  10. Article

    Open Access

    DJ-1 protects against cell death following acute cardiac ischemia–reperfusion injury

    Novel therapeutic targets are required to protect the heart against cell death from acute ischemia–reperfusion injury (IRI). Mutations in the DJ-1 (PARK7) gene in dopaminergic neurons induce mitochondrial dysf...

    R K Dongworth, U A Mukherjee, A R Hall, R Astin, S-B Ong, Z Yao in Cell Death & Disease (2014)

  11. No Access

    Article

    The Mitochondrial Permeability Transition Pore as a Target for Cardioprotection in Hypertrophic Cardiomyopathy

    P. S. C. Rees, S. M. Davidson, S. E. Harding in Cardiovascular Drugs and Therapy (2013)

  12. No Access

    Article

    Investigating the Signal Transduction Pathways Underlying Remote Ischemic Conditioning in the Porcine Heart

    The mechanism underlying remote ischemic conditioning (RIC) remains unclear. We investigated whether RIC protects the heart through the activation of the adenosine receptor and the PI3K-Akt pathway at the onse...

    D. J. Hausenloy, E. K. Iliodromitis, I. Andreadou in Cardiovascular Drugs and Therapy (2012)

  13. No Access

    Article

    The Cardioprotective Effect of Necrostatin Requires the Cyclophilin-D Component of the Mitochondrial Permeability Transition Pore

    Necrostatin (Nec-1) protects against ischemia–reperfusion (IR) injury in both brain and heart. We have previously reported in this journal that necrostatin can delay opening of the mitochondrial permeability t...

    S. Y. Lim, S. M. Davidson, M. M. Mocanu, D. M. Yellon in Cardiovascular Drugs and Therapy (2007)

  14. No Access

    Article

    Erythropoietin protects the myocardium against reperfusion injury in vitro and in vivo

    Erythropoietin (EPO) is a hormone that is currently used to treat patients with renal failure and anaemia. However, it has also been shown to protect against ischaemia/reperfusion injury; this protection occur...

    A. J. Bullard, P. Govewalla, D. M. Yellon in Basic Research in Cardiology (2005)

  15. Article

    Open Access

    Representational difference analysis of cDNA identifies novel genes expressed following preconditioning of the heart

    Preconditioning of the myocardium rapidly induces a number of transcription factors, which are likely to be responsible for a cascade of transcriptional changes underlying the development of delayed adaptation...

    M A C Fauchon, T J Pell, G F Baxter, D M Yellon in Experimental & Molecular Medicine (2005)

  16. Article

    40th EASD Annual Meeting of the European Association for the Study of Diabetes

    M. Veitenhansl, K. Stegner, F.-X. Hierl, C. Dieterle, H. Feldmeier, B. Gutt in Diabetologia (2004)

  17. No Access

    Article

    Omapatrilat Limits Infarct Size and Lowers the Threshold for Induction of Myocardial Preconditioning Through a Bradykinin Receptor-Mediated Mechanism

    Bradykinin is an important endogenous trigger of myocardial ischemic preconditioning (IPC). Through simultaneous inhibition of neutral endopeptidase and angiotensin converting enzyme, omapatrilat prevents enzy...

    Z. Ebrahim, G.F. Baxter, D.M. Yellon in Cardiovascular Drugs and Therapy (2004)

  18. No Access

    Article

    Adenosine A1 Agonist at Reperfusion Trial (AART): Results of a Three-Center, Blinded, Randomized, Controlled Experimental Infarct Study

    Adenosine A1 receptor agonists given prior to myocardial ischemia limit ischemic injury in several species. However, the ability of adenosine receptor agonists to limit infarct size when given at reperfusion has ...

    G.F. Baxter, S.L. Hale, T. Miki, R.A. Kloner in Cardiovascular Drugs and Therapy (2000)

  19. No Access

    Article

    Enhanced Protection of Heat Shock in Myocardial Infarction: Inhibition of Detrimental Effect of Systemic Hyperthermia

    Summary. We have shown that isolated blood-perfused heat-stressed hearts are protected only when the blood donor animal has not been exposed to hyperthermia. Systematic hyperthermia results in larger infarctio...

    E.K. Iliodromitis, G.K. Karavolias, E. Bofilis in Cardiovascular Drugs and Therapy (1999)

  20. No Access

    Chapter

    Heat Stress Proteins and Their Relationship to Myocardial Protection

    Acute myocardial infarction is the most common cause of death in men in the Western world. The treatment of this condition is no longer simply supportive, awaiting the complications of ischaemic injury, but ha...

    R. Carroll, D. M. Yellon in Stress Proteins (1999)

previous disabled Page of 3